II. Pathophysiology
- Mechanism
- Antidiuretic Hormone (ADH) deficiency
- Contrast with Nephrogenic Diabetes Insipidus (deficient renal response to ADH)
- Antidiuretic Hormone (ADH) deficiency
-
Polyuria
- Decreased ADH release
- Permanent Polyuria
- Central lesion above median eminence
- Transient Polyuria
- Central lesion below median eminence
- ADH passes via Hypothalamus to portal capillaries
- Results in ADH release below the median eminence
III. Etiology
- Idiopathic (30%)
- Autoimmune Disease (common)
- Lymphocyte inflammation
- Pituitary stalk (thickened stalk on MRI)
- Posterior pituitary
- Anterior Pituitary deficiency
- Growth Hormone
- ACTH deficient
- Lymphocyte inflammation
- Familial Diabetes Insipidus (very rare)
- Point mutation in ADH precursor gene
- Precursor accumulates
- Toxicity to ADH synthesizing cells
- Enhancement within Hypothalamus on MRI
- Point mutation in ADH precursor gene
- Autoimmune Disease (common)
-
Severe Traumatic Brain Injury
- Hypothalamus or pituitary injury
- Neurosurgery (Transsphenoidal)
- Results from Hypothalamus or Pituitary Trauma
- Most common cause of Polyuria post neurosurgery
- Differential Diagnosis
- Excess fluids
- Mannitol
- Corticosteroids
- Approach
- Check Urine Osmolality
- Observe response to water restriction
- Malignancy
- Examples: Lung Cancer, Leukemia, Lymphoma
- Polyuria may be presenting symptom
- Langerhans Histiocytosis (Histiocytosis X)
- Infiltrative disease
- Sarcoidosis causes similar infiltration
- Post SVT resolution
- Anorexia Nervosa
- Pregnancy exacerbates any of above forms
IV. Diagnosis
-
Fluid Deprivation Test
- No response to water deprivation
- Response to exogenous ADH administration
-
Hare-Hickey Test
- Decreased ADH to Serum Osmolality ratio
V. Radiology: MRI Head
- Central DI: Diminished signal at posterior pituitary
VI. Management
- General Measures that potentiate ADH
- dDAVP (Desmopressin)
-
Chlorpropamide 125-250 mg PO qd-bid
- Antidiuretic effect - may lower Urine Output by 50%
- Risk of Hypoglycemia at higher doses
-
Carbamazepine 100-300 mg bid
- Enhances ADH response
- May lower Urine Output by 50%
-
Hydrochlorothiazide with low salt intake
- Decreases Polyuria
- Dose: 25 mg qd to bid